(NYSE: AVNT) Avient's forecast annual revenue growth rate of 3.74% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.61%.
Avient's revenue in 2024 is $3,151,400,000.On average, 5 Wall Street analysts forecast AVNT's revenue for 2024 to be $294,132,988,574, with the lowest AVNT revenue forecast at $291,104,967,300, and the highest AVNT revenue forecast at $295,871,491,545. On average, 5 Wall Street analysts forecast AVNT's revenue for 2025 to be $309,284,417,720, with the lowest AVNT revenue forecast at $305,715,003,300, and the highest AVNT revenue forecast at $312,231,901,171.
In 2026, AVNT is forecast to generate $325,858,225,184 in revenue, with the lowest revenue forecast at $320,964,228,375 and the highest revenue forecast at $329,431,383,426.